Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer

MLA

Fabin Dang, et al. “Inhibition of CK1ε Potentiates the Therapeutic Efficacy of CDK4/6 Inhibitor in Breast Cancer.” Nature Communications, vol. 12, no. 1, Sept. 2021, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41467-021-25700-6.

APA

Fabin Dang, Li Nie, Jin Zhou, Kouhei Shimizu, Chen Chu, Zhong Wu, Anne Fassl, Shizhong Ke, Yuangao Wang, Jinfang Zhang, Tao Zhang, Zhenbo Tu, Hiroyuki Inuzuka, Piotr Sicinski, Adam J. Bass, & Wenyi Wei. (2021). Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer. Nature Communications, 12(1), 1–15. https://doi.org/10.1038/s41467-021-25700-6

Chicago

Fabin Dang, Li Nie, Jin Zhou, Kouhei Shimizu, Chen Chu, Zhong Wu, Anne Fassl, et al. 2021. “Inhibition of CK1ε Potentiates the Therapeutic Efficacy of CDK4/6 Inhibitor in Breast Cancer.” Nature Communications 12 (1): 1–15. doi:10.1038/s41467-021-25700-6.